During the last session, Mira Pharmaceuticals Inc (NASDAQ:MIRA)’s traded shares were 4.79 million, with the beta value of the company hitting 3.86. At the end of the trading day, the stock’s price was $2.19, reflecting an intraday loss of -0.45% or -$0.01. The 52-week high for the MIRA share is $6.40, that puts it down -192.24 from that peak though still a striking 76.71% gain since the share price plummeted to a 52-week low of $0.51. The company’s market capitalization is $32.37M, and the average intraday trading volume over the past 10 days was 5.94 million shares, and the average trade volume was 2.08 million shares over the past three months.
Mira Pharmaceuticals Inc (NASDAQ:MIRA) trade information
Mira Pharmaceuticals Inc (MIRA) registered a -0.45% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.45% in intraday trading to $2.19, hitting a weekly high. The stock’s 5-day price performance is 93.81%, and it has moved by 82.50% in 30 days. Based on these gigs, the overall price performance for the year is 12.89%. The short interest in Mira Pharmaceuticals Inc (NASDAQ:MIRA) is 0.34 million shares and it means that shorts have 0.7 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mira Pharmaceuticals Inc (MIRA) estimates and forecasts
Statistics show that Mira Pharmaceuticals Inc has underperformed its competitors in share price, compared to the industry in which it operates. Mira Pharmaceuticals Inc (MIRA) shares have gone up 171.07% during the last six months, with a year-to-date growth rate less than the industry average at 6.25% against 17.30.
While earnings are projected to return 21.88% in 2024.
MIRA Dividends
Mira Pharmaceuticals Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Mira Pharmaceuticals Inc (NASDAQ:MIRA)’s Major holders
Mira Pharmaceuticals Inc insiders own 27.21% of total outstanding shares while institutional holders control 5.03%, with the float percentage being 6.91%.
